author-photo

F. De Braud

European Institute of Oncology

55

Papers

1192

Citations

Citation Trend

Filter By

Papers (55) Sort By

Journal Conference Others

Combination of the indoleamine 2,3-dioxygenase 1 inhibitor (IDO1i) BMS-986205 with nivolumab (nivo): Updated safety across all tumors and efficacy in advanced bladder cancer (advBC) by patient (pt) subgroup

2019 European Urology Supplements
Show All
- Source
- Cite
- Save
Citations (1)
Pembrolizumab and nanoparticle albumin bound paclitaxel (nab-paclitaxel) for metastatic urothelial carcinoma (UC) after chemotherapy failure: The open-label, single-arm, phase 2 PEANUT study

2017 European Urology Supplements
Show All
- Source
- Cite
- Save
Citations (0)
Phase I study of PF-03446962, a fully human monoclonal antibody against activin receptor–like kinase 1 in patients with hepatocellular carcinoma

2016 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (22)
1144 A phase 2 study of the Aurora Kinase-A (AAK) tyrosine kinase inhibitor (TKI) alisertib (MLN8237) in patients (pts) with pre-treated urothelial cancer (UC)

2016 European Urology Supplements
Show All
- Source
- Cite
- Save
Citations (0)
Thalidomide in patients with advanced hepatocellular carcinoma: A clinical/biological study

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
29LBA Entrectinib (RXDX-101), an oral pan-Trk, ROS1, and ALK inhibitor in patients with advanced solid tumors harboring gene rearrangements

2015 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (12)
3098 Nivolumab (NIVO) monotherapy or in combination with ipilimumab (IPI) for treatment of recurrent small cell lung cancer (SCLC)

2015 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (5)
A phase I, dose-escalation study of volasertib combined with nintedanib in advanced solid tumors.

2015 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (20)
1032PPROLONGED ANTI-TUMOR ACTIVITY OF LUCITANIB IN ADVANCED THYROID CANCER

2014 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Targeting the MET gene for the treatment of non-small-cell lung cancer

2014 Critical Reviews in Oncology Hematology
Show All
- Source
- Cite
- Save
Citations (61)